Dr Ahmed Kaseb

      

Dr Ahmed Kaseb

Editor-in-Chief: Dr. Ahmed Kaseb

Dr. Ahmed Kaseb is an Associate Professor and Program Director of Hepatocellular Carcinoma (HCC), in the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Dr. Kaseb received his medical degree from Cairo University, and worked as a research fellow at University of Michigan, in Ann Arbor for two years focusing on cancer biomarkers before starting Internal Medicine Residency at Wayne State University, in Detroit, Michigan where he excelled in clinical training and was the recipient of The Best Resident Award in 2003-2004. He then finished Medical oncology fellowship at Henry Ford Hospital, in Detroit, Michigan where he continued his translational research work which led to three major publications presenting circulating biomarkers for early cancer detection in the area of bladder and prostate cancers and his work on HCC biomarkers was subsequently initiated. Dr. Kaseb’s work received international awards from the American Society of Clinical Oncology (ASCO) an American College of Physicians (ACP).

Dr. Kaseb joined the department of Gastrointestinal Medical Oncology, at the University of Texas MD Anderson Cancer Center in 2007 to lead the HCC program. Dr. Kaseb is heavily involved in HCC clinical research where he has served as principal investigator on multiple clinical trials. Dr. Kaseb’s principal research interests include HCC systemic and multi-disciplinary therapies, in addition to molecular staging studies. His research also examines the differential effects of demographics and hepatitis status on treatment outcome in HCC. Based on his interest and research, he has developed several protocols in the treatment and staging of HCC. His published studies have yielded impressive results. Dr. Kaseb’s work has contributed greatly to the understanding of HCC interdisciplinary therapies and molecular staging, and has received governmental and pharmaceutical funding for several projects and clinical trials.

Dr. Kaseb has extensively authored and co-authored dozens of papers and books. Dr. Kaseb serves as an Editor and Scientific Reviewer for several international medical journals, and has received several national and international awards throughout his career. He is an active member of several international societies and has served on several committees and advisory boards at the national and international levels, and has participated in several international expert consensus conferences in the area of HCC.